India’s drug regulator, the Central Drugs Standard Control Organization (CDSCO), approved Novo Nordisk’s Wegovy (semaglutide injection 2.4 mg) on 17 July 2026 for the treatment of metabolic dysfunction-associated...
July 17, 2026
Science & Technology